North Eastern Carrying Corporation Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: April 10, 2025, 10:35 am

Competitors of North Eastern Carrying Corporation Ltd

All Competitor Stocks of North Eastern Carrying Corporation Ltd

Quarterly Result

Last Updated: March 4, 2025, 10:59 am

Below is a detailed analysis of the quarterly data for North Eastern Carrying Corporation Ltd based on the most recent figures (Dec 2024) and their trends compared to the previous period:

• For Sales, as of Dec 2024, the value is 81.05 Cr.. The value appears to be declining and may need further review. It has decreased from 81.94 Cr. (Sep 2024) to 81.05 Cr., marking a decrease of 0.89 Cr..
• For Expenses, as of Dec 2024, the value is 75.74 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 75.39 Cr. (Sep 2024) to 75.74 Cr., marking an increase of 0.35 Cr..
• For Operating Profit, as of Dec 2024, the value is 5.31 Cr.. The value appears to be declining and may need further review. It has decreased from 6.55 Cr. (Sep 2024) to 5.31 Cr., marking a decrease of 1.24 Cr..
• For OPM %, as of Dec 2024, the value is 6.55%. The value appears to be declining and may need further review. It has decreased from 7.99% (Sep 2024) to 6.55%, marking a decrease of 1.44%.
• For Other Income, as of Dec 2024, the value is 0.03 Cr.. The value appears to be declining and may need further review. It has decreased from 0.05 Cr. (Sep 2024) to 0.03 Cr., marking a decrease of 0.02 Cr..
• For Interest, as of Dec 2024, the value is 1.86 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1.90 Cr. (Sep 2024) to 1.86 Cr., marking a decrease of 0.04 Cr..
• For Depreciation, as of Dec 2024, the value is 0.56 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.68 Cr. (Sep 2024) to 0.56 Cr., marking a decrease of 0.12 Cr..
• For Profit before tax, as of Dec 2024, the value is 2.92 Cr.. The value appears to be declining and may need further review. It has decreased from 4.02 Cr. (Sep 2024) to 2.92 Cr., marking a decrease of 1.10 Cr..
• For Tax %, as of Dec 2024, the value is 33.22%. The value appears to be increasing, which may not be favorable. It has increased from 28.61% (Sep 2024) to 33.22%, marking an increase of 4.61%.
• For Net Profit, as of Dec 2024, the value is 1.94 Cr.. The value appears to be declining and may need further review. It has decreased from 2.87 Cr. (Sep 2024) to 1.94 Cr., marking a decrease of 0.93 Cr..
• For EPS in Rs, as of Dec 2024, the value is 0.20. The value appears to be declining and may need further review. It has decreased from 0.30 (Sep 2024) to 0.20, marking a decrease of 0.10.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: March 6, 2025, 3:20 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: November 14, 2024, 7:57 pm

Below is a detailed analysis of the balance sheet data for North Eastern Carrying Corporation Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:

• For Equity Capital, as of Sep 2024, the value is ₹100.00 Cr.. The value appears strong and on an upward trend. It has increased from 95.00 Cr. (Mar 2024) to ₹100.00 Cr., marking an increase of 5.00 Cr..
• For Reserves, as of Sep 2024, the value is ₹115.00 Cr.. The value appears strong and on an upward trend. It has increased from 99.00 Cr. (Mar 2024) to ₹115.00 Cr., marking an increase of 16.00 Cr..
• For Borrowings, as of Sep 2024, the value is ₹95.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 103.00 Cr. (Mar 2024) to ₹95.00 Cr., marking a decrease of 8.00 Cr..
• For Other Liabilities, as of Sep 2024, the value is ₹20.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 20.00 Cr..
• For Total Liabilities, as of Sep 2024, the value is ₹330.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 317.00 Cr. (Mar 2024) to ₹330.00 Cr., marking an increase of 13.00 Cr..
• For Fixed Assets, as of Sep 2024, the value is ₹9.00 Cr.. The value appears to be declining and may need further review. It has decreased from 13.00 Cr. (Mar 2024) to ₹9.00 Cr., marking a decrease of 4.00 Cr..
• For CWIP, as of Sep 2024, the value is ₹0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Investments, as of Sep 2024, the value is ₹5.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 5.00 Cr..
• For Other Assets, as of Sep 2024, the value is ₹316.00 Cr.. The value appears strong and on an upward trend. It has increased from 299.00 Cr. (Mar 2024) to ₹316.00 Cr., marking an increase of 17.00 Cr..
• For Total Assets, as of Sep 2024, the value is ₹330.00 Cr.. The value appears strong and on an upward trend. It has increased from 317.00 Cr. (Mar 2024) to ₹330.00 Cr., marking an increase of 13.00 Cr..

Notably, the Reserves (115.00 Cr.) exceed the Borrowings (95.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for North Eastern Carrying Corporation Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 17, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 16) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 17, the value is 1.12. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 16) which recorded 1.12.
• For Diluted EPS (Rs.), as of Mar 17, the value is 1.12. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 16) which recorded 1.12.
• For Cash EPS (Rs.), as of Mar 17, the value is 1.65. This value is below the healthy minimum of 3. It has decreased from 1.73 (Mar 16) to 1.65, marking a decrease of 0.08.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 17, the value is 15.63. It has increased from 14.52 (Mar 16) to 15.63, marking an increase of 1.11.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 17, the value is 15.63. It has increased from 14.52 (Mar 16) to 15.63, marking an increase of 1.11.
• For Revenue From Operations / Share (Rs.), as of Mar 17, the value is 109.17. It has increased from 107.25 (Mar 16) to 109.17, marking an increase of 1.92.
• For PBDIT / Share (Rs.), as of Mar 17, the value is 3.94. This value is within the healthy range. It has decreased from 4.12 (Mar 16) to 3.94, marking a decrease of 0.18.
• For PBIT / Share (Rs.), as of Mar 17, the value is 3.40. This value is within the healthy range. It has decreased from 3.51 (Mar 16) to 3.40, marking a decrease of 0.11.
• For PBT / Share (Rs.), as of Mar 17, the value is 1.79. This value is within the healthy range. It has increased from 1.78 (Mar 16) to 1.79, marking an increase of 0.01.
• For Net Profit / Share (Rs.), as of Mar 17, the value is 1.12. This value is below the healthy minimum of 2. There is no change compared to the previous period (Mar 16) which recorded 1.12.
• For NP After MI And SOA / Share (Rs.), as of Mar 17, the value is 1.12. This value is below the healthy minimum of 2. There is no change compared to the previous period (Mar 16) which recorded 1.12.
• For PBDIT Margin (%), as of Mar 17, the value is 3.60. This value is below the healthy minimum of 10. It has decreased from 3.83 (Mar 16) to 3.60, marking a decrease of 0.23.
• For PBIT Margin (%), as of Mar 17, the value is 3.11. This value is below the healthy minimum of 10. It has decreased from 3.26 (Mar 16) to 3.11, marking a decrease of 0.15.
• For PBT Margin (%), as of Mar 17, the value is 1.64. This value is below the healthy minimum of 10. It has decreased from 1.66 (Mar 16) to 1.64, marking a decrease of 0.02.
• For Net Profit Margin (%), as of Mar 17, the value is 1.02. This value is below the healthy minimum of 5. It has decreased from 1.04 (Mar 16) to 1.02, marking a decrease of 0.02.
• For NP After MI And SOA Margin (%), as of Mar 17, the value is 1.02. This value is below the healthy minimum of 8. It has decreased from 1.04 (Mar 16) to 1.02, marking a decrease of 0.02.
• For Return on Networth / Equity (%), as of Mar 17, the value is 7.13. This value is below the healthy minimum of 15. It has decreased from 7.73 (Mar 16) to 7.13, marking a decrease of 0.60.
• For Return on Capital Employeed (%), as of Mar 17, the value is 19.98. This value is within the healthy range. It has decreased from 22.58 (Mar 16) to 19.98, marking a decrease of 2.60.
• For Return On Assets (%), as of Mar 17, the value is 3.16. This value is below the healthy minimum of 5. It has decreased from 3.37 (Mar 16) to 3.16, marking a decrease of 0.21.
• For Long Term Debt / Equity (X), as of Mar 17, the value is 0.08. This value is below the healthy minimum of 0.2. It has increased from 0.06 (Mar 16) to 0.08, marking an increase of 0.02.
• For Total Debt / Equity (X), as of Mar 17, the value is 1.06. This value exceeds the healthy maximum of 1. It has decreased from 1.07 (Mar 16) to 1.06, marking a decrease of 0.01.
• For Asset Turnover Ratio (%), as of Mar 17, the value is 3.19. It has decreased from 3.26 (Mar 16) to 3.19, marking a decrease of 0.07.
• For Current Ratio (X), as of Mar 17, the value is 1.68. This value is within the healthy range. It has increased from 1.62 (Mar 16) to 1.68, marking an increase of 0.06.
• For Quick Ratio (X), as of Mar 17, the value is 1.68. This value is within the healthy range. It has increased from 1.62 (Mar 16) to 1.68, marking an increase of 0.06.
• For Interest Coverage Ratio (X), as of Mar 17, the value is 2.45. This value is below the healthy minimum of 3. It has increased from 2.39 (Mar 16) to 2.45, marking an increase of 0.06.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 17, the value is 1.70. This value is below the healthy minimum of 3. It has increased from 1.65 (Mar 16) to 1.70, marking an increase of 0.05.
• For Enterprise Value (Cr.), as of Mar 17, the value is 380.47. It has increased from 303.70 (Mar 16) to 380.47, marking an increase of 76.77.
• For EV / Net Operating Revenue (X), as of Mar 17, the value is 0.69. This value is below the healthy minimum of 1. It has increased from 0.56 (Mar 16) to 0.69, marking an increase of 0.13.
• For EV / EBITDA (X), as of Mar 17, the value is 19.25. This value exceeds the healthy maximum of 15. It has increased from 14.70 (Mar 16) to 19.25, marking an increase of 4.55.
• For MarketCap / Net Operating Revenue (X), as of Mar 17, the value is 0.54. This value is below the healthy minimum of 1. It has increased from 0.42 (Mar 16) to 0.54, marking an increase of 0.12.
• For Price / BV (X), as of Mar 17, the value is 3.83. This value exceeds the healthy maximum of 3. It has increased from 3.14 (Mar 16) to 3.83, marking an increase of 0.69.
• For Price / Net Operating Revenue (X), as of Mar 17, the value is 0.54. This value is below the healthy minimum of 1. It has increased from 0.42 (Mar 16) to 0.54, marking an increase of 0.12.
• For EarningsYield, as of Mar 17, the value is 0.01. This value is below the healthy minimum of 5. It has decreased from 0.02 (Mar 16) to 0.01, marking a decrease of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness